Viral Infection in Enhance the Inflammatory Bowel Disease in Children: A Review
Infeksi Virus dalam Meningkatkan Penyakit Radang Usus pada Anak: Sebuah Tinjauan
DOI:
https://doi.org/10.21070/ijhsm.v2i1.121Keywords:
Viral Infection, Enhanced, Inflammatory Bowel DiseaseAbstract
Viral infections, which typically have a high rate of morbidity and mortality, are more challenging to identify. In particular, studies on rotavirus, hepatitis B virus, bacteriophages, enteric viruses, cytomegalovirus, and Epstein-Barr virus were evaluated for IBD. These results suggest that IBD patients are more likely to get viral infections. Therefore, medical practitioners should be more aware of the increased risk of viral infections in patients with inflammatory bowel disease. The incidence and prevalence of childhood-onset inflammatory bowel diseases (IBD), which include ulcerative colitis and Crohn's disease subtypes, have significantly increased in recent years, making them important pediatric chronic diseases on a global scale. Childhood-onset IBD is more widespread and dangerous than adult-onset IBD. The biological treatment for juvenile IBD is anti-tumor necrosis factor therapy, and more treatment options are urgently needed. Currently, this patient population is prescribed off-label other biologic medicines such as Steinman, and vedolizumab. Understanding the viral infection's causes, diagnosing and tracking the illness, treating patients, and managing the psychological and physical effects of having IBD are all crucial. Globally, the frequency of IBD varies greatly; estimates place the number of affected individuals at 2.2 million in Europe and 1.6 million in the United States.
Highlights:
- Viral infections increase risk in IBD patients; awareness is crucial.
- Childhood-onset IBD is rising; better treatments are urgently needed.
- Global IBD cases exceed 3.8 million; management and diagnosis are vital.
Keywords: Viral Infection, Enhanced, Inflammatory Bowel Disease
References
[1]. T. Dehghani, O. Gholizadeh, M. Daneshvar, M. M. Nemati, S. Akbarzadeh, P. Amini, H. Afkhami, M. Kohansal, Z. Javanmard, and V. Poortahmasebi, “Association between inflammatory bowel disease and viral infections,” Current Microbiology, vol. 80, no. 6, p. 195, Jun. 2023.
[2]. M. A. Atiyah, A. S. Khudhair, H. H. Abdul-Ra'aoof, A. M. Tiryag, S. B. Dawood, and S. K. Jassim, “Nurses' knowledge and attitudes about enteral feeding complications by nasogastric tube in intensive care units,” Rawal Medical Journal, vol. 48, no. 3, p. 689, Sep. 2023.
[3]. R. Enaud and T. Lamireau, “Differential diagnosis of inflammatory bowel disease,” in Pediatric Inflammatory Bowel Disease, Cham, Switzerland: Springer International Publishing, Feb. 2023, pp. 217–228.
[4]. A. M. Tiryag, “Nurses’ knowledge and attitudes toward pacemaker: A cross-sectional study,” Academia Open, vol. 9, no. 1, pp. 10–21070, Jun. 2024.
[5]. J. Burisch, M. Zhao, S. Odes, P. De Cruz, S. Vermeire, C. N. Bernstein, G. G. Kaplan, D. Duricova, D. Greenberg, H. O. Melberg, and M. Watanabe, “The cost of inflammatory bowel disease in high-income settings: A Lancet Gastroenterology & Hepatology Commission,” The Lancet Gastroenterology & Hepatology, vol. 8, no. 5, pp. 458–492, May 2023.
[6]. S. K. Jassim, Z. Abbass, and A. M. Tiryag, “A study of diabetes correlated emotional distress among patients with type 2 diabetes mellitus: A cross-sectional study,” Academia Open, vol. 9, no. 2, pp. 10–21070, Oct. 2024.
[7]. C. Le Berre, S. Danese, and L. Peyrin-Biroulet, “Can we change the natural course of inflammatory bowel disease?” Therapeutic Advances in Gastroenterology, vol. 16, p. 17562848231163118, Apr. 2023.
[8]. Z. Abbass, S. K. Jassim, A. F. Sadeq, S. Hafedh, A. M. Tiryag, and H. H. AL-Hadrawi, “Determination of self-efficacy level: The capacity of patients with hypertension to manage their chronic disease,” Indonesian Journal on Health Science and Medicine, vol. 1, no. 2, pp. 10–21070, Nov. 2024.
[9]. L. Degli Esposti, M. Daperno, M. Dovizio, A. Franchi, D. Sangiorgi, E. V. Savarino, F. Scaldaferri, O. Secchi, A. Serra, V. Perrone, and A. Armuzzi, “A retrospective analysis of treatment patterns, drug discontinuation, and healthcare costs in Crohn's disease patients treated with biologics,” Digestive and Liver Disease, vol. 55, no. 9, pp. 1214–1220, Sep. 2023.
[10]. F. A. Jassim, A. M. Tiryag, and S. S. Issa, “Effect of bad habits on the growth of school students: A cross-sectional study,” Indonesian Journal on Health Science and Medicine, vol. 1, no. 1, pp. 10–21070, Jul. 2024.
[11]. K. Lewandowski, M. Kaniewska, M. Więcek, P. Szwarc, P. Panufnik, E. Tulewicz-Marti, M. Walicka, E. Franek, and G. Rydzewska, “Risk factors for osteoporosis among patients with inflammatory bowel disease—Do we already know everything?” Nutrients, vol. 15, no. 5, p. 1151, Feb. 2023.
[12]. K. M. Jassim, A. S. Khudhair, Z. S. Dawood, and A. M. Tiryag, “Nurses’ knowledge about electrocardiogram interpretation: A cross-sectional study,” Rawal Medical Journal, vol. 48, no. 4, p. 850, Oct. 2023.
[13]. A. H. Fadhil, H. S. Kadhim, R. J. Hussain, and S. A. Al-Atrooshi, “The possible role of HCMV in inflammatory bowel diseases in a sample of Iraqi patients,” Iraqi Journal of Medical Sciences, vol. 17, no. 3–4, pp. 207–214, 2019.
[14]. Z. S. Dawood, K. M. Jassim, A. M. Tiryag, and A. S. Khudhair, “Nurses' knowledge and attitudes toward deep vein thrombosis: A cross-sectional study,” Bahrain Medical Bulletin, vol. 45, no. 4, Dec. 2023.
[15]. B. P. Abraham, S. Mehta, and H. B. El-Serag, “Natural history of pediatric-onset inflammatory bowel disease: A systematic review,” Journal of Clinical Gastroenterology, vol. 46, no. 7, pp. 581–589, Aug. 2012.
[16]. M. F. Hasan, W. F. Hussein, A. M. Tiryag, I. J. Ali, and Z. M. Shaker, “Nurses’ knowledge toward lower back pain: A cross-sectional study,” Academia Open, vol. 9, no. 1, pp. 10–21070, Jun. 2024.
[17]. J. Martín-de-Carpi, A. Rodríguez, E. Ramos, S. Jiménez, M. J. Martínez-Gómez, E. Medina, and SPIRIT-IBD Working Group of SEGHNP, “Increasing incidence of pediatric inflammatory bowel disease in Spain (1996–2009): The SPIRIT Registry,” Inflammatory Bowel Diseases, vol. 19, no. 1, pp. 73–80, Jan. 2013.
[18]. M. A. Mohammad, F. A. Jassim, and A. M. Tiryag, “Single-use flexible ureteroscope for the treatment of renal stone,” Revista Latinoamericana de Hipertensión, vol. 18, no. 7, Dec. 2023.
[19]. M. Castro, B. Papadatou, M. Baldassare, F. Balli, A. Barabino, C. Barbera, S. Barca, G. Barera, F. Bascietto, B. R. Canani, and M. Calacoci, “Inflammatory bowel disease in children and adolescents in Italy: Data from the pediatric national IBD register (1996–2003),” Inflammatory Bowel Diseases, vol. 14, no. 9, pp. 1246–1252, Sep. 2008.
[20]. M. Mohammad, F. Jassim, and A. Tiryag, “Retrograde intrarenal lithotripsy using disposable flexible ureteroscope,” Georgian Medical News, vol. 348, pp. 44–46, Mar. 2024.
[21]. M. B. Heyman, B. S. Kirschner, B. D. Gold, G. Ferry, R. Baldassano, S. A. Cohen, H. S. Winter, P. Fain, C. King, T. Smith, and H. B. El-Serag, "Children with Early-Onset Inflammatory Bowel Disease (IBD): Analysis of a Pediatric IBD Consortium Registry," The Journal of Pediatrics, vol. 146, no. 1, pp. 35-40, Jan. 2005.
[22]. A. A. Al-Iedan, M. A. Akber, S. B. Dawood, A. I. Alobaidi, S. S. Issa, H. H. Raaoof, A. Z. Khalaf, and A. M. Tiryag, "Bridging the Gap: Enhancing Open Fracture Care in Emergency Nursing," Academia Open, vol. 9, no. 1, p. 10-21070, Jun. 2024.
[23]. C. G. Sauer and S. Kugathasan, "Pediatric Inflammatory Bowel Disease: Highlighting Pediatric Differences in IBD," Gastroenterology Clinics, vol. 38, no. 4, pp. 611-628, Dec. 2009.
[24]. M. A. Mohammad, A. Y. Al-Timary, and A. M. Tiryag, "Safety of Tubeless Double Access Percutaneous Nephrolithotomy Compared to Single Access Approach," Bahrain Medical Bulletin, vol. 45, no. 2, Jun. 2023.
[25]. E. I. Benchimol, K. J. Fortinsky, P. Gozdyra, M. Van den Heuvel, J. Van Limbergen, and A. M. Griffiths, "Epidemiology of Pediatric Inflammatory Bowel Disease: A Systematic Review of International Trends," Inflammatory Bowel Diseases, vol. 17, no. 1, pp. 423-439, Jan. 2011.
[26]. M. Jabbar, M. Mohammad, and A. Tiryag, "Changes in Male Reproductive Hormones in Patients with COVID-19," Georgian Medical News, vol. 342, pp. 42-46, Sep. 2023.
[27]. N. Wallaschek, S. Reuter, S. Silkenat, K. Wolf, C. Niklas, Ö. Kayisoglu, C. Aguilar, A. Wiegering, C. T. Germer, S. Kircher, and A. Rosenwald, "Ephrin Receptor A2, the Epithelial Receptor for Epstein-Barr Virus Entry, is Not Available for Efficient Infection in Human Gastric Organoids," PLoS Pathogens, vol. 17, no. 2, p. e1009210, Feb. 2021.
[28]. M. A. Mohammad, H. H. Abdul-Ra’aoof, K. A. Razzaq Manahi, and A. M. Tiryag, "Parents’ Knowledge and Attitudes Toward Testicular Torsion," Bahrain Medical Bulletin, vol. 46, no. 1, Mar. 2024.
[29]. F. Lu, K. A. Martin, S. S. Soldan, A. V. Kossenkov, P. Wickramasinghe, O. Vladimirova, A. De Leo, C. Lin, Y. Nefedova, and P. M. Lieberman, "Defective Epstein-Barr Virus Genomes and Atypical Viral Gene Expression in B-Cell Lines Derived from Multiple Myeloma Patients," Journal of Virology, vol. 95, no. 13, p. 10-128, Jun. 2021.
[30]. A. M. Tiryag, S. B. Dawood, and S. K. Jassim, "Nurses’ Knowledge and Attitudes About Enteral Feeding Complications by Nasogastric Tube in Intensive Care Units," Rawal Medical Journal, vol. 48, no. 3, pp. 689-693, Jul. 2023.
[31]. V. Craviotto, F. Furfaro, L. Loy, A. Zilli, L. Peyrin-Biroulet, G. Fiorino, S. Danese, and M. Allocca, "Viral Infections in Inflammatory Bowel Disease: Tips and Tricks for Correct Management," World Journal of Gastroenterology, vol. 27, no. 27, p. 4276, Jul. 2021.
[32]. M. A. Akber, A. M. Tiryag, and A. I. Alobaidi, "Nurses’ Knowledge Concerning Developmental Dysplasia of the Hip: A Cross-Sectional Study," American Journal of Pediatric Medicine and Health Sciences, vol. 2, no. 4, pp. 155-160, 2024.
[33]. S. Lei, H. Samuel, E. Twitchell, T. Bui, A. Ramesh, K. Wen, M. Weiss, G. Li, X. Yang, X. Jiang, and L. Yuan, "Enterobacter Cloacae Inhibits Human Norovirus Infectivity in Gnotobiotic Pigs," Scientific Reports, vol. 6, no. 1, p. 25017, Apr. 2016.
[34]. M. A. Akber, A. M. Tiryag, and A. I. Alobaidi, "Nurses’ Knowledge Regarding Cast Complications of Limb Fractures: A Cross-Sectional Study," Central Asian Journal of Medical and Natural Science, vol. 5, no. 2, pp. 195-200, Apr. 2024.
[35]. J. E. Axelrad, A. Joelson, P. H. Green, G. Lawlor, S. Lichtiger, K. Cadwell, and B. Lebwohl, "Enteric Infections are Common in Patients with Flares of Inflammatory Bowel Disease," Official Journal of the American College of Gastroenterology | ACG, vol. 113, no. 10, pp. 1530-1539, Oct. 2018.
[36]. H. M. Sabty, S. B. Dawood, and A. M. Tiryag, "Nurses’ Knowledge and Practices on Influenza Vaccination for Pregnant Women," Jurnal Kebidanan Midwiferia, vol. 10, no. 2, pp. 50-59, Oct. 2024.
[37]. K. H. Hamza, E. Dunér, I. Ulmert, A. Arias, D. Sorobetea, and K. Lahl, "Minor Alterations in the Intestinal Microbiota Composition Upon Rotavirus Infection Do Not Affect Susceptibility to DSS Colitis," Scientific Reports, vol. 11, no. 1, p. 13485, Jun. 2021.
[38]. A. M. Tiryag, M. A. Atiyah, and A. S. Khudhair, "Nurses' Knowledge and Attitudes Toward Thyroidectomy: A Cross-Sectional Study," Health Education and Health Promotion, vol. 10, no. 3, pp. 459-465, Jul. 2022.
[39]. E. Liles, S. A. Irving, P. Dandamudi, E. A. Belongia, M. F. Daley, F. DeStefano, L. A. Jackson, S. J. Jacobsen, E. Kharbanda, N. P. Klein, and E. Weintraub, "Incidence of Pediatric Inflammatory Bowel Disease Within the Vaccine Safety Datalink Network and Evaluation of Association with Rotavirus Vaccination," Vaccine, vol. 39, no. 27, pp. 3614-3620, Jun. 2021.
[40]. H. H. Abdul-Ra’aoof, M. A. Akber, F. A. Jassim, A. M. Tiryag, S. S. Issa, M. A. Atiyah, J. A. Mezail, and I. S. Hassan, "The Psychological Impact of Violence on Emergency Department and Intensive Care Unit Nurses: A Cross-Sectional Study," Research Journal of Trauma and Disability Studies, vol. 3, no. 4, pp. 228-233, Apr. 2024.
[41]. G. Losurdo, A. Iannone, A. Contaldo, M. Barone, E. Ierardi, A. Di Leo, and M. Principi, "Chronic Viral Hepatitis in a Cohort of Inflammatory Bowel Disease Patients from Southern Italy: A Case-Control Study," Pathogens, vol. 9, no. 11, p. 870, Oct. 2020.
[42]. A. M. Tiryag, "Revitalizing Hearts: The Transformative Impact of Pacemaker Therapy on Cardiac Conduction Disorders," Academia Open, vol. 9, no. 1, pp. 10-21070, Jun. 2024.
[43]. G. H. Bai, S. C. Lin, Y. H. Hsu, and S. Y. Chen, "The Human Virome: Viral Metagenomics, Relations with Human Diseases, and Therapeutic Applications," Viruses, vol. 14, no. 2, p. 278, Jan. 2022.
[44]. E. H. Rahi, Z. M. Al-Hejaj, and A. M. Tiryag, "Nurses' Knowledge of Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study," Academia Open, vol. 9, no. 2, pp. 10-21070, Jun. 2024.
[45]. J. Babickova and R. Gardlik, "Pathological and Therapeutic Interactions Between Bacteriophages, Microbes and the Host in Inflammatory Bowel Disease," World Journal of Gastroenterology, vol. 21, no. 40, pp. 11321-11330, Oct. 2015.
[46]. I. H. Zainel, H. H. Abdul-Ra'aoof, and A. M. Tiryag, "Mothers' Knowledge and Attitudes Towards Their Children with Neonatal Jaundice: A Cross-Sectional Study," Health Education and Health Promotion, vol. 10, no. 3, pp. 565-570, Jul. 2022.
[47]. M. D. Long et al., "Prevalence and Epidemiology of Overweight and Obesity in Children with Inflammatory Bowel Disease," Inflammatory Bowel Diseases, vol. 17, no. 10, pp. 2162-2168, Oct. 2011.
[48]. H. H. Abdul-Ra’aoof, A. M. Tiryag, and M. A. Atiyah, "Knowledge, Attitudes, and Practice of Nursing Students About Insulin Therapy: A Cross-Sectional Study," Academia Open, vol. 9, no. 1, pp. 10-21070, Jun. 2024.
[49]. B. Zeisler et al., "Outcome Following Aminosalicylate Therapy in Children Newly Diagnosed as Having Ulcerative Colitis," Journal of Pediatric Gastroenterology and Nutrition, vol. 56, no. 1, pp. 12-18, Jan. 2013.
[50]. H. H. Abdul-Ra’aoof et al., "Moderate Proficiency in Suture Techniques Among Nurses: A Cross-Sectional Study," Journal of Nursing Education and Practice, vol. 14, no. 2, pp. 50-58, Jun. 2024.
[51]. D. R. Mack et al., "Laboratory Values for Children with Newly Diagnosed Inflammatory Bowel Disease," Pediatrics, vol. 119, no. 6, pp. 1113-1119, Jun. 2007.
[52]. A. M. Tiryag and H. H. Atiyah, "Nurses’ Knowledge Toward Bariatric Surgery at Surgical Wards at Teaching Hospitals in Al-Basra City," Indian Journal of Forensic Medicine & Toxicology, vol. 15, no. 3, pp. 5152-5159, Jun. 2021.
[53]. P. Henderson, N. H. Anderson, and D. C. Wilson, "The Diagnostic Accuracy of Fecal Calprotectin During the Investigation of Suspected Pediatric Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis," American College of Gastroenterology, vol. 109, no. 5, pp. 637-645, May 2014.
[54]. A. M. Tiryag and H. H. Atiyah, "Nurses' Knowledge Toward Obesity in Al-Basra City," Annals of the Romanian Society for Cell Biology, vol. 25, no. 5, pp. 4667-4673, 2021.
[55]. A. Zholudev et al., "Serologic Testing with ANCA, ASCA, and Anti-OmpC in Children and Young Adults with Crohn’s Disease and Ulcerative Colitis: Diagnostic Value and Correlation with Disease Phenotype," American College of Gastroenterology, vol. 99, no. 11, pp. 2235-2241, Nov. 2004.
[56]. M. C. Dubinsky et al., "Increased Immune Reactivity Predicts Aggressive Complicating Crohn’s Disease in Children," Clinical Gastroenterology and Hepatology, vol. 6, no. 10, pp. 1105-1111, Oct. 2008.
[57]. P. Minar et al., "Utility of Neutrophil Fcγ Receptor I (CD64) Index as a Biomarker for Mucosal Inflammation in Pediatric Crohn's Disease," Inflammatory Bowel Diseases, vol. 20, no. 6, pp. 1037-1048, Jun. 2014.
[58]. R. Maltz, D. J. Podberesky, and S. A. Saeed, "Imaging Modalities in Pediatric Inflammatory Bowel Disease," Current Opinion in Pediatrics, vol. 26, no. 5, pp. 590-596, Oct. 2014.
[59]. M. J. Rosen et al., "Endoscopic Ultrasound to Guide the Combined Medical and Surgical Management of Pediatric Perianal Crohn’s Disease," Inflammatory Bowel Diseases, vol. 16, no. 3, pp. 461-468, Mar. 2010.
[60]. J. Tung et al., "A Population-Based Study of the Frequency of Corticosteroid Resistance and Dependence in Pediatric Patients with Crohn’s Disease and Ulcerative Colitis," Inflammatory Bowel Diseases, vol. 12, no. 12, pp. 1093-1100, Dec. 2006.
[61]. R. Modigliani et al., "Clinical, Biological, and Endoscopic Picture of Attacks of Crohn’s Disease: Evolution on Prednisolone," Gastroenterology, vol. 98, no. 4, pp. 811-818, 2020.
[62]. A. Levine et al., "A Comparison of Budesonide and Prednisone for the Treatment of Active Pediatric Crohn’s Disease," Journal of Pediatric Gastroenterology and Nutrition, vol. 36, no. 2, pp. 248-252, 2024.
[63]. W. J. Sandborn et al., "Once-Daily Budesonide MMX Extended-Release Tablets Induce Remission in Patients with Mild to Moderate Ulcerative Colitis: Results from the CORE I Study," Gastroenterology, vol. 143, no. 5, pp. 1218-1226, Nov. 2012.
[64]. X. Roblin, S. Pillet, A. Oussalah, P. Berthelot, E. Del Tedesco, J. M. Phelip, M. L. Chambonnière, O. Garraud, L. Peyrin-Biroulet, and B. Pozzetto, "Cytomegalovirus Load in Inflamed Intestinal Tissue is Predictive of Resistance to Immunosuppressive Therapy in Ulcerative Colitis," Am. Coll. Gastroenterol., vol. 106, no. 11, pp. 2001-2008, Nov. 2011.
[65]. J. Critch, A. S. Day, A. Otley, C. King-Moore, J. E. Teitelbaum, H. Shashidhar, and NASPGHAN IBD Committee, "Use of Enteral Nutrition for the Control of Intestinal Inflammation in Pediatric Crohn's Disease," J. Pediatr. Gastroenterol. Nutr., vol. 54, no. 2, pp. 298-305, Feb. 2012.
[66]. B. G. Feagan and J. K. MacDonald, "Oral 5-Aminosalicylic Acid for Induction of Remission in Ulcerative Colitis," Cochrane Database Syst. Rev., no. 10, 2012.
[67]. J. A. Quiros, M. B. Heyman, J. F. Pohl, T. M. Attard, H. J. Pieniaszek, E. Bortey, K. Walker, and W. P. Forbes, "Safety, Efficacy, and Pharmacokinetics of Balsalazide in Pediatric Patients with Mild-to-Moderate Active Ulcerative Colitis: Results of a Randomized, Double-Blind Study," J. Pediatr. Gastroenterol. Nutr., vol. 49, no. 5, pp. 571-579, Nov. 2009.
[68]. B. Zeisler, T. Lerer, J. Markowitz, D. Mack, A. Griffiths, A. Bousvaros, D. Keljo, J. Rosh, J. Evans, M. Kappelman, and A. Otley, "Outcome Following Aminosalicylate Therapy in Children Newly Diagnosed as Having Ulcerative Colitis," J. Pediatr. Gastroenterol. Nutr., vol. 56, no. 1, pp. 12-18, Jan. 2013.
[69]. J. S. Hyams, T. Lerer, D. Mack, A. Bousvaros, A. Griffiths, J. Rosh, A. Otley, J. Evans, M. Stephens, M. Kay, and D. Keljo, "Outcome Following Thiopurine Use in Children with Ulcerative Colitis: A Prospective Multicenter Registry Study," Am. Coll. Gastroenterol., vol. 106, no. 5, pp. 981-987, May 2011.
[70]. P. S. Dulai, K. D. Thompson, H. B. Blunt, M. C. Dubinsky, and C. A. Siegel, "Risks of a Serious Infection or Lymphoma with Anti-Tumor Necrosis Factor Therapy for Pediatric Inflammatory Bowel Disease: A Systematic Review," Clin. Gastroenterol. Hepatol., vol. 12, no. 9, pp. 1443-1451, Sep. 2014.
[71]. J. S. Hyams, A. Griffiths, J. Markowitz, R. N. Baldassano, W. A. Faubion Jr, R. B. Colletti, M. Dubinsky, J. Kierkus, J. Rosh, Y. Wang, and B. Huang, "Safety and Efficacy of Adalimumab for Moderate to Severe Crohn's Disease in Children," Gastroenterology, vol. 143, no. 2, pp. 365-374, Aug. 2012.
[72]. D. S. Kotlyar, M. T. Osterman, R. H. Diamond, D. Porter, W. C. Blonski, M. Wasik, S. Sampat, M. Mendizabal, M. V. Lin, and G. R. Lichtenstein, "A Systematic Review of Factors That Contribute to Hepatosplenic T-Cell Lymphoma in Patients with Inflammatory Bowel Disease," Clin. Gastroenterol. Hepatol., vol. 9, no. 1, pp. 36-41, Jan. 2011.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Indonesian Journal on Health Science and Medicine

This work is licensed under a Creative Commons Attribution 4.0 International License.